bf/NASDAQ:BNTX_icon.jpeg

NASDAQ:BNTX

BioNTech SE

  • Stock

USD

Last Close

84.68

26/07 20:00

Market Cap

19.33B

Beta: 0.22

Volume Today

265.19K

Avg: 618.15K

PE Ratio

7.56

PFCF: 4.40

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.57M
-
4.83M
35.33%
8.76M
81.18%
37.92M
333.11%
283.31M
647.11%
471.05M
66.27%
398.65M
15.37%
average payables
29.38M
-
47.13M
60.42%
31.11M
33.99%
61.39M
97.34%
131.14M
113.61%
182.05M
38.82%
279.05M
53.28%
average receivables
7.53M
-
18.77M
149.13%
24.32M
29.60%
93.29M
283.54%
6.27B
6,625.84%
9.76B
55.62%
4.74B
51.43%
book value per share
-0.22
-
1.17
639.91%
2.33
98.88%
5.42
132.11%
48.74
800.03%
82.44
69.12%
84.15
2.07%
capex per share
-0.25
-
-0.30
17.51%
-0.34
12.36%
-0.34
0.37%
-0.63
87.10%
-1.49
136.61%
-2.93
96.36%
capex to depreciation
-5.48
-
-3.09
43.72%
-2.10
32.06%
-2.21
5.17%
-2.05
7.14%
-2.95
43.88%
-3.85
30.56%
capex to operating cash flow
1.10
-
1.17
6.17%
0.36
69.30%
6.34
1,671.29%
-0.17
102.73%
-0.03
84.54%
-0.13
390.86%
capex to revenue
-0.94
-
-0.53
43.26%
-0.65
23.07%
-0.18
72.94%
-0.01
95.42%
-0.02
158.61%
-0.18
780.23%
cash per share
0.76
-
1.82
138.95%
2.46
35.65%
5.32
116.02%
8.50
59.81%
57.81
580.04%
68.78
18.98%
days of inventory on hand
14.92
-
13.48
9.65%
17.55
30.16%
33.23
89.36%
47.51
42.98%
35.40
25.48%
217.67
514.82%
days payables outstanding
202.25
-
97.16
51.96%
30.68
68.42%
53.01
72.74%
15.13
71.46%
16.44
8.67%
215.42
1,210.52%
days sales outstanding
53.89
-
81.37
51.00%
67.92
16.53%
125.90
85.38%
238.16
89.17%
150.68
36.73%
223.62
48.41%
debt to assets
0.08
-
0.19
144.32%
0.09
50.25%
0.10
3.62%
0.10
7.98%
0.02
81.62%
0.01
52.14%
0.01
4.48%
debt to equity
0.97
-
-1.41
245.11%
0.23
116.06%
0.16
31.74%
0.18
12.91%
0.03
85.52%
0.01
58.26%
0.01
2.28%
dividend yield
0.01
-
earnings yield
-0.03
-
-0.02
46.60%
-0.03
64.60%
0.00
103.20%
0.19
20,587.77%
0.28
48.75%
0.04
85.31%
enterprise value
-277.01M
-
2.57B
1,026.44%
2.46B
3.96%
5.95B
141.28%
16.00B
169.01%
54.15B
238.51%
20.56B
62.02%
11.53B
43.94%
enterprise value over ebitda
-52.65
-
-82.13
56.01%
-40.68
50.47%
-379.90
833.79%
3.62
100.95%
1.57
56.59%
9.98
535.42%
ev to operating cash flow
-48.83
-
-42.36
13.24%
-29.95
29.29%
-1.19K
3,863.86%
60.87
105.13%
1.51
97.51%
2.15
41.70%
ev to sales
41.66
-
19.32
53.63%
54.76
183.47%
33.17
39.44%
2.85
91.40%
1.19
58.37%
3.02
154.10%
free cash flow per share
-0.49
-
-0.56
14.26%
-1.27
129.46%
-0.39
69.37%
3.02
872.08%
54.32
1,701.44%
19.39
64.30%
free cash flow yield
-0.04
-
-0.04
8.84%
-0.04
5.63%
-0.01
86.17%
0.01
327.19%
0.39
2,814.68%
0.20
47.39%
graham net net
-1.07
-
0.22
120.71%
1.12
409.19%
2.20
95.85%
31.46
1,329.15%
67.50
114.58%
65.35
3.18%
graham number
1.36
-
2.36
73.98%
6.67
182.13%
2.70
59.45%
215.09
7,854.60%
268.20
24.69%
85.56
68.10%
income quality
0.61
-
1.22
99.50%
1.11
9.36%
0.09
91.65%
0.06
36.02%
1.05
1,672.55%
4.53
332.07%
intangibles to total assets
0.03
-
0.22
677.32%
0.13
39.52%
0.11
16.84%
0.07
37.11%
0.01
81.87%
0.01
26.18%
0.05
437.29%
interest coverage
-90.65
-
-31.29
65.48%
-105.66
237.64%
-1.27
98.80%
2.83K
223,145.39%
668.93
76.37%
89.22
86.66%
interest debt per share
0.31
-
0.27
11.70%
0.37
34.97%
1.20
225.63%
1.26
4.41%
0.95
24.48%
0.94
0.75%
inventory turnover
24.46
-
27.07
10.68%
20.80
23.17%
10.99
47.19%
7.68
30.06%
10.31
34.18%
1.68
83.73%
invested capital
0.97
-
-1.41
245.11%
0.23
116.06%
0.16
31.74%
0.18
12.91%
0.03
85.52%
0.01
58.26%
0.01
2.28%
market cap
2.69B
-
2.82B
4.98%
6.40B
126.69%
16.97B
165.24%
55.54B
227.36%
34.23B
38.38%
22.97B
32.88%
net current asset value
-39.98M
-
-233.28M
483.56%
62.98M
127.00%
256.00M
306.50%
720.12M
181.30%
11.14B
1,446.29%
18.70B
67.92%
16.77B
10.33%
net debt to ebitda
2.50
-
11.91
376.67%
3.08
74.13%
23.04
647.84%
-0.09
100.40%
-1.04
1,022.66%
-9.91
849.45%
net income per share
-0.38
-
-0.21
43.94%
-0.85
300.22%
0.06
107.08%
42.18
70,203.96%
38.78
8.07%
3.87
90.03%
operating cash flow per share
-0.23
-
-0.26
10.69%
-0.94
266.03%
-0.05
94.33%
3.65
6,954.76%
55.81
1,430.58%
22.33
60.00%
payables turnover
1.80
-
3.76
108.16%
11.90
216.65%
6.89
42.11%
24.13
250.41%
22.20
7.98%
1.69
92.37%
receivables turnover
6.77
-
4.49
33.77%
5.37
19.81%
2.90
46.06%
1.53
47.14%
2.42
58.06%
1.63
32.62%
research and ddevelopement to revenue
1.39
-
1.12
19.22%
2.09
86.01%
1.34
35.88%
0.01
99.60%
0.01
23.82%
0.47
6,867.55%
return on tangible assets
-0.29
-
-0.08
71.11%
-0.25
197.64%
0.01
102.79%
0.66
9,238.85%
0.41
37.88%
0.04
89.59%
revenue per share
0.27
-
0.56
107.11%
0.51
8.70%
1.90
270.88%
77.77
3,984.38%
71.16
8.51%
15.87
77.69%
roe
1.74
-
-0.18
110.38%
-0.36
101.24%
0.01
103.05%
0.87
7,711.29%
0.47
45.64%
0.05
90.23%
roic
-3.00
-
-0.17
94.43%
-0.32
90.44%
0.01
101.68%
0.86
15,986.64%
0.45
47.10%
0.03
94.22%
sales general and administrative to revenue
0.37
-
0.19
49.27%
0.37
98.79%
0.19
47.97%
0.01
92.47%
0.03
90.79%
0.13
362.91%
shareholders equity per share
-0.22
-
1.17
639.91%
2.33
98.88%
5.42
132.11%
48.74
800.03%
82.44
69.12%
84.15
2.07%
stock based compensation to revenue
0.10
-
0.06
37.56%
0.28
364.88%
0.07
76.07%
0.00
93.63%
0.01
47.89%
0.01
114.53%
tangible asset value
20.67M
-
-131.74M
737.24%
178.96M
235.84%
404.06M
125.78%
1.21B
199.06%
11.69B
867.54%
19.84B
69.66%
19.08B
3.81%
tangible book value per share
-0.58
-
0.79
235.84%
1.91
142.18%
4.77
149.70%
47.92
904.42%
81.54
70.17%
79.30
2.74%
working capital
261.49M
-
31.09M
88.11%
322.84M
938.30%
422.01M
30.72%
1.06B
151.39%
11.59B
992.55%
18.97B
63.68%
17.46B
7.98%

All numbers in USD (except ratios and percentages)